Healius Pathology Pty Ltd T/A Dorevitch Pathology
[2021] FWCA 4688
•2 AUGUST 2021
| [2021] FWCA 4688 |
| FAIR WORK COMMISSION |
DECISION |
Fair Work Act 2009
s.185—Enterprise agreement
Healius Pathology Pty Ltd T/A Dorevitch Pathology
(AG2021/6275)
HEALIUS PATHOLOGY PTY LTD TRADING AS DOREVITCH PATHOLOGY SUPPORT EMPLOYEES ENTERPRISE AGREEMENT 2021
Health and welfare services | |
DEPUTY PRESIDENT BOYCE | SYDNEY, 2 AUGUST 2021 |
Application for approval of the Healius Pathology Pty Ltd trading as Dorevitch Pathology Support Employees Enterprise Agreement 2021.
[1] An application has been made for approval of an enterprise agreement to be known as the Healius Pathology Pty Ltd trading as Dorevitch Pathology Support Employees Enterprise Agreement 2021 (Agreement). The application was made pursuant to s.185 of the Fair Work Act 2009 (Act). It has been made by Healius Pathology Pty Ltd T/A Dorevitch Pathology (Employer). The Agreement is a single enterprise agreement.
[2] The Employer has provided written undertakings dated 30 July 2021. Those undertakings are attached at Annexure A to this decision and become terms of the Agreement. I am satisfied that the undertakings will not cause financial detriment to any employee covered by the Agreement (as compared to the relevant provisions of the Health Professionals and Support Services Award 2020 and the Nurses Award 2020), and that the undertakings will not result in substantial changes to the Agreement.
[3] The following employee organisations (all of which were bargaining representatives for the Agreement), have given notice under s.183 of the Act that they want to be covered by the Agreement:
Australian Nursing and Midwifery Federation (ANMF); and
Health Services Union Australia Victoria No. 1 Branch T/A Health Workers Union (HWU).
[4] In accordance with s.201(2) of the Act, I note that the Agreement covers these organisations.
[5] Subject to the undertakings referred to above, I am satisfied that each of the requirements of ss.186, 187, 188 and 190 of the Act, as are relevant to this application for approval, have been met.
[6] I am satisfied the more beneficial entitlements of the NES will prevail where there is an inconsistency between the Agreement and the NES.
[7] The Agreement is approved and, in accordance with s.54 of the Act, will operate from 9 August 2021. The nominal expiry date of the Agreement is 1 July 2025.
DEPUTY PRESIDENT
Printed by authority of the Commonwealth Government Printer
<AE512571 PR732387>
Annexure A
0
0
0